Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
ROE, % ? -89.2% 3.46% -10.7% -33.6% -30.7%   -41.1%  
Changes by years, y/y, % -71pp +93pp -14pp -23pp +3pp     +11.1%

Arcturus Therapeutics Holdings. ROE, %

Arcturus Therapeutics Holdings. ROE, changes, pp

Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
ROE, % ? -29.2% -26.0% -29.7% -30.7% -41.1%   -41.1%
Changes by years, y/y, % +11pp +2pp -6pp +3pp -12pp    
Changes by quarters, q/q, % +4pp +3pp -4pp -1pp -10pp    

Arcturus Therapeutics Holdings. ROE, %

Arcturus Therapeutics Holdings. ROE, changes, pp

Arcturus Therapeutics Holdings. ROE, changes, pp